Finance

Stocks in Focus: Lloyds Banking Group (NYSE:LYG), ServiceNow (NYSE:NOW), Cutera (NASDAQ:CUTR), Trulia (NYSE:TRLA), OvaScience, Inc. (NASDAQ:OVAS)

Lloyds Banking Group PLC (NYSE:LYG)‘s stock had its “buy” rating restated by research analysts at Investec in a report released on Tuesday. Lloyds Banking Group plc (NYSE:LYG) belongs to Financial sector. Its net profit margin is -4.90% and weekly performance is 2.59%. On last trading day company shares ended up $5.15. Lloyds Banking Group plc (NYSE:LYG) distance from 50-day simple moving average (SMA50) is 0.84%.

ServiceNow (NYSE:NOW) Insider Frederic B. Luddy sold 151,400 shares of the stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $56.11, for a total value of $8,495,054.00. Following the transaction, the insider now directly owns 501,587 shares in the company, valued at approximately $28,144,047. The transaction was disclosed in a document filed with the SEC. ServiceNow, Inc. (NYSE:NOW) shares moved up 1.55% in last trading session and ended the day at $59.73. NOW Gross Margin is 63.30% and its return on assets is -12.50%. ServiceNow, Inc. (NYSE:NOW) quarterly performance is 11.00%.

Cutera, Inc. (NASDAQ:CUTR) reported financial results for the second quarter ended June 30, 2014. Net loss was $2.7 million, or $0.19 per diluted share. On 26 August, Cutera, Inc. (NASDAQ:CUTR) shares moved up 0.84% and was closed at $9.56. CUTR EPS growth in last 5 year was -8.40%. Cutera, Inc. (NASDAQ:CUTR) year to date (YTD) performance is -6.09%.

Trulia (NASDAQ:TRLA) has been given a consensus recommendation of “Hold” by the fifteen ratings firms that are covering the company. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the company. Trulia, Inc. (NYSE:TRLA) ended the last trading day at $62.44. Company weekly volatility is calculated as 3.31%and price to cash ratio as 10.84. Trulia, Inc. (NYSE:TRLA) showed a weekly performance of 6.08%.

Wedbush reaffirmed their buy rating on shares of Ovascience (NASDAQ:OVAS) in a research report released on Tuesday. OvaScience, Inc. (NASDAQ:OVAS) shares moved up 4.30% in last trading session and ended the day on $12.85. OVAS return on assets is -51.40%. OvaScience, Inc. (NASDAQ:OVAS) quarterly performance is 73.18%.